NO20006088L - Fremgangsmåter for å öke nivåer av acetylcholin - Google Patents

Fremgangsmåter for å öke nivåer av acetylcholin

Info

Publication number
NO20006088L
NO20006088L NO20006088A NO20006088A NO20006088L NO 20006088 L NO20006088 L NO 20006088L NO 20006088 A NO20006088 A NO 20006088A NO 20006088 A NO20006088 A NO 20006088A NO 20006088 L NO20006088 L NO 20006088L
Authority
NO
Norway
Prior art keywords
acetylcholine
methods
increase levels
levels
increase
Prior art date
Application number
NO20006088A
Other languages
English (en)
Other versions
NO20006088D0 (no
Inventor
Henry Uhlman Bryant
Michele Anette Glinn
Steven Mark Paus
Xin Wu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20006088L publication Critical patent/NO20006088L/no
Publication of NO20006088D0 publication Critical patent/NO20006088D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører en fremgangsmåte for å øke nivåer av acetylcholin omfattende å administrere til et pattedyr som har behov for dette, en effektiv mengde av en forbindelse med formel (I), og eventuelt en AChE hemmer.
NO20006088A 1998-06-16 2000-11-30 Fremgangsmåter for å öke nivåer av acetylcholin NO20006088D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8948898P 1998-06-16 1998-06-16
PCT/US1999/012603 WO1999065309A1 (en) 1998-06-16 1999-06-04 Methods for increasing levels of acetylcholine

Publications (2)

Publication Number Publication Date
NO20006088L true NO20006088L (no) 2000-11-30
NO20006088D0 NO20006088D0 (no) 2000-11-30

Family

ID=22217922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006088A NO20006088D0 (no) 1998-06-16 2000-11-30 Fremgangsmåter for å öke nivåer av acetylcholin

Country Status (17)

Country Link
EP (1) EP0966964A1 (no)
JP (1) JP2002518299A (no)
KR (1) KR20010052892A (no)
CN (1) CN1305343A (no)
AU (1) AU748659B2 (no)
BR (1) BR9911217A (no)
CA (1) CA2333453A1 (no)
HR (1) HRP20000861A2 (no)
HU (1) HUP0103834A2 (no)
IL (1) IL138914A0 (no)
NO (1) NO20006088D0 (no)
PL (1) PL346242A1 (no)
SK (1) SK18812000A3 (no)
TR (1) TR200003714T2 (no)
TW (1) TW486367B (no)
WO (1) WO1999065309A1 (no)
ZA (1) ZA200005885B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
JP2002518329A (ja) 1998-06-16 2002-06-25 イーライ・リリー・アンド・カンパニー アセチルコリンレベルを増加させる方法
KR101226702B1 (ko) * 2010-10-08 2013-01-25 충북대학교 산학협력단 인간 콜린 아세틸트랜스퍼라아제를 발현하는 인간 신경줄기세포 및 이의 용도
KR102117741B1 (ko) * 2017-12-31 2020-06-01 롯데첨단소재(주) 도금용 열가소성 수지 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09507071A (ja) * 1993-12-21 1997-07-15 イーライ・リリー・アンド・カンパニー アミロイド原性ペプチドに関連した状態を治療又は予防する方法
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
AR003930A1 (es) * 1995-02-28 1998-09-30 Lilly Co Eli Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
ES2188946T3 (es) * 1996-06-07 2003-07-01 Eisai Co Ltd Polimorfos de clorhidrato de donepecil y proceso de fabricacion de los mismos.
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.

Also Published As

Publication number Publication date
BR9911217A (pt) 2001-03-06
PL346242A1 (en) 2002-01-28
TR200003714T2 (tr) 2001-07-23
TW486367B (en) 2002-05-11
EP0966964A1 (en) 1999-12-29
JP2002518299A (ja) 2002-06-25
AU4819199A (en) 2000-01-05
HUP0103834A2 (hu) 2002-05-29
IL138914A0 (en) 2001-11-25
ZA200005885B (en) 2001-10-22
HRP20000861A2 (en) 2001-10-31
WO1999065309A1 (en) 1999-12-23
KR20010052892A (ko) 2001-06-25
AU748659B2 (en) 2002-06-06
NO20006088D0 (no) 2000-11-30
CN1305343A (zh) 2001-07-25
SK18812000A3 (sk) 2002-01-07
CA2333453A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
ATE226193T1 (de) Substituierte zyklische amine als metalloproteaseinhibitoren
TR200200082T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
NO962568L (no) Anvendelse av PLA2 inhibitorer som behandling for Alzheimers sykdom
NO20044807L (no) Heratitt C virus inhibitorer
NO970161L (no) Triazolforbindelser og anvendelse derav
NO20003018D0 (no) Triazinangiogenese-inhibitorer
DE69419141D1 (de) Inhibitoren gegen thrombose
NO20054970L (no) Arylsubstituerte byrazolforbindelser anvendbare som kinaseinhibitorer
NO942064L (no) yminhibitorer
WO2002076440A3 (en) Methods of treating alzheimer's disease with piperidin derivates
BR9712792A (pt) Inibidores de metaloprotease bidentada.
DE69735442D1 (de) Antidiabetische mittel
AU2251901A (en) Methods and compounds for inhibiting MRP1
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
NO20002371L (no) 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom
NO970340L (no) Organiske forbindelser
TR200102514T2 (tr) COPD tedavisi için metod
NO20006087L (no) Fremgangsmåter for å öke nivåer av acetylcholin
EA200101001A1 (ru) Декурсинол или его производное в качестве аналгезирующего средства
ATE180485T1 (de) Nitrone verwendbar zum abfangen von freien radikalen
PT1276722E (pt) Inibidores de naftamidina-uroquinase
DE59604916D1 (de) Stabilisierte hydroxylaminlösungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application